June 17, 2010
Health Care Reform 101: For Life Sciences Cos.
Law360
Healthcare & Life Sciences and Public Policy & Regulation Partners Michael Gaba and Michael Werner authored a Law360 article titled, "Health Care Reform 101: For Life Sciences Cos.
While most of the popular press surrounding the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act has focused on patients, providers and payers, the law also significantly changes how life sciences companies will do business.
Spurred by the desire to reduce health care costs while increasing quality of care, Congress has increased the government's ability to promote the development of new products and test the effectiveness of old ones. The law creates a host of new opportunities for companies to advance their products, as well as new challenges they need to address.
While most of the popular press surrounding the Patient Protection and Affordable Care Act and the Health Care and Education Reconciliation Act has focused on patients, providers and payers, the law also significantly changes how life sciences companies will do business.
Spurred by the desire to reduce health care costs while increasing quality of care, Congress has increased the government's ability to promote the development of new products and test the effectiveness of old ones. The law creates a host of new opportunities for companies to advance their products, as well as new challenges they need to address.